Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients ...Middle East

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., March 28, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced topline...

Hence then, the article about shanton reveals topline data from phase 2b study in refractory gout patients was published today ( Friday 28/03/2025 - 04:02 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Shanton Reveals Topline Data from Phase 2b Study in Refractory Gout Patients )

Also on site :

• Tornado warning issued, and quickly cancelled, over Alhambra
• Governor Hochul: Annual statewide donation drive is complete
• Skier dies in collision with tree at Colorado’s Aspen Mountain, resort officials confirm